GlassScriptPhysician profile
Austin Rubel
NPI 1417241282
$2,749.49
in general payments reported to CMS, 2019-2025
6 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $10.99 · 2021: $917 · 2022: $83.33 · 2023: $203 · 2024: $189 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $1,313.02 | 2019-2023 | Nobelactive |
| Straumann USA LLC | $1,099.20 | 2021-2025 | |
| Salvin Dental Specialties, INC. | $193.13 | 2021 | |
| Henry Schein, INC. | $91.66 | 2025 | Nuoss, Allooss Allograft Putty, Ace Surgical Supply |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $33.33 | 2023 | |
| Ace Surgical Supply Co., INC. | $19.15 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Rubel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.